Loading…

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice

The COVID-19 pandemic has revealed that infection with SARS-CoV-2 can result in a wide range of clinical outcomes in humans. An incomplete understanding of immune correlates of protection represents a major barrier to the design of vaccines and therapeutic approaches to prevent infection or limit di...

Full description

Saved in:
Bibliographic Details
Published in:PLoS pathogens 2021-01, Vol.17 (1), p.e1009287-e1009287
Main Authors: Graham, Jessica B, Swarts, Jessica L, Leist, Sarah R, Schäfer, Alexandra, Menachery, Vineet D, Gralinski, Lisa E, Jeng, Sophia, Miller, Darla R, Mooney, Michael A, McWeeney, Shannon K, Ferris, Martin T, Pardo-Manuel de Villena, Fernando, Heise, Mark T, Baric, Ralph S, Lund, Jennifer M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443
cites cdi_FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443
container_end_page e1009287
container_issue 1
container_start_page e1009287
container_title PLoS pathogens
container_volume 17
creator Graham, Jessica B
Swarts, Jessica L
Leist, Sarah R
Schäfer, Alexandra
Menachery, Vineet D
Gralinski, Lisa E
Jeng, Sophia
Miller, Darla R
Mooney, Michael A
McWeeney, Shannon K
Ferris, Martin T
Pardo-Manuel de Villena, Fernando
Heise, Mark T
Baric, Ralph S
Lund, Jennifer M
description The COVID-19 pandemic has revealed that infection with SARS-CoV-2 can result in a wide range of clinical outcomes in humans. An incomplete understanding of immune correlates of protection represents a major barrier to the design of vaccines and therapeutic approaches to prevent infection or limit disease. This deficit is largely due to the lack of prospectively collected, pre-infection samples from individuals that go on to become infected with SARS-CoV-2. Here, we utilized data from genetically diverse Collaborative Cross (CC) mice infected with SARS-CoV to determine whether baseline T cell signatures are associated with a lack of viral control and severe disease upon infection. SARS-CoV infection of CC mice results in a variety of viral load trajectories and disease outcomes. Overall, a dysregulated, pro-inflammatory signature of circulating T cells at baseline was associated with severe disease upon infection. Our study serves as proof of concept that circulating T cell signatures at baseline can predict clinical and virologic outcomes upon SARS-CoV infection. Identification of basal immune predictors in humans could allow for identification of individuals at highest risk of severe clinical and virologic outcomes upon infection, who may thus most benefit from available clinical interventions to restrict infection and disease.
doi_str_mv 10.1371/journal.ppat.1009287
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2490314839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A650814602</galeid><doaj_id>oai_doaj_org_article_be424a125c6f47b582b6def18907ae94</doaj_id><sourcerecordid>A650814602</sourcerecordid><originalsourceid>FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443</originalsourceid><addsrcrecordid>eNqVUk1v1DAQjRCIlsI_QGCJCxx28cR27FyQlhUfK1UgdQtXy3EmW6-ycRonKyr-PA6bVl3UC_LB9vi9N56ZlyQvgc6BSXi_9UPXmHretqafA6V5quSj5BSEYDPJJH9873ySPAthSykHBtnT5IQxASwFepr8_mgC1q5Bckks1jVxu90Qb-0VNr6_aTGQtsPS2Z7sXedrv3GWmKYkpQsYqcT6po9xMrS-IevFxXq29D-Jayq0vYsh15Clr2tT-M70bo9k2fkQyM5ZfJ48qUwd8MW0nyU_Pn-6XH6dnX__slouzmc2y6CflZCBVFXGCmuR2soAFIxiYQTPhQJbyMIWAoGa-GRiWaAKEFKIjFvMOWdnyeuDblv7oKe-BZ3ynDLgiuURsTogSm-2uu3cznQ32hun_wZ8t9Gm652tURfIU24gFTaruCyESousxApUTqWJ6aLWhynbUOywtBj7Y-oj0eOXxl3pjd9rqaRguYoCbyeBzl8PGHq9c2GcjWnQD-O_FVMgZTbmevMP9OHqJtTGxALiaHzMa0dRvcgEVcAzmkbU_AFUXCXGYfkGKxfjR4R3R4TRCfir35ghBL1aX_wH9tsxlh-wdnRKh9Vd74Dq0fq3RerR-nqyfqS9ut_3O9Kt19kftEr_5g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2490314839</pqid></control><display><type>article</type><title>Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Graham, Jessica B ; Swarts, Jessica L ; Leist, Sarah R ; Schäfer, Alexandra ; Menachery, Vineet D ; Gralinski, Lisa E ; Jeng, Sophia ; Miller, Darla R ; Mooney, Michael A ; McWeeney, Shannon K ; Ferris, Martin T ; Pardo-Manuel de Villena, Fernando ; Heise, Mark T ; Baric, Ralph S ; Lund, Jennifer M</creator><contributor>Subbarao, Kanta</contributor><creatorcontrib>Graham, Jessica B ; Swarts, Jessica L ; Leist, Sarah R ; Schäfer, Alexandra ; Menachery, Vineet D ; Gralinski, Lisa E ; Jeng, Sophia ; Miller, Darla R ; Mooney, Michael A ; McWeeney, Shannon K ; Ferris, Martin T ; Pardo-Manuel de Villena, Fernando ; Heise, Mark T ; Baric, Ralph S ; Lund, Jennifer M ; Subbarao, Kanta</creatorcontrib><description>The COVID-19 pandemic has revealed that infection with SARS-CoV-2 can result in a wide range of clinical outcomes in humans. An incomplete understanding of immune correlates of protection represents a major barrier to the design of vaccines and therapeutic approaches to prevent infection or limit disease. This deficit is largely due to the lack of prospectively collected, pre-infection samples from individuals that go on to become infected with SARS-CoV-2. Here, we utilized data from genetically diverse Collaborative Cross (CC) mice infected with SARS-CoV to determine whether baseline T cell signatures are associated with a lack of viral control and severe disease upon infection. SARS-CoV infection of CC mice results in a variety of viral load trajectories and disease outcomes. Overall, a dysregulated, pro-inflammatory signature of circulating T cells at baseline was associated with severe disease upon infection. Our study serves as proof of concept that circulating T cell signatures at baseline can predict clinical and virologic outcomes upon SARS-CoV infection. Identification of basal immune predictors in humans could allow for identification of individuals at highest risk of severe clinical and virologic outcomes upon infection, who may thus most benefit from available clinical interventions to restrict infection and disease.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1009287</identifier><identifier>PMID: 33513210</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animal diseases ; Animal models ; Animals ; Biology and Life Sciences ; Body weight loss ; Clinical outcomes ; Collaboration ; Coronaviruses ; Correlation ; COVID-19 ; COVID-19 - genetics ; COVID-19 - immunology ; COVID-19 - virology ; Disease control ; Female ; Genetic aspects ; Genetics ; Health aspects ; Humans ; Immune response ; Immune system ; Inbreeding ; Infections ; Inflammation ; Lungs ; Lymphocytes ; Lymphocytes T ; Male ; Medicine and Health Sciences ; Mice ; Mice, Inbred C57BL ; Middle East respiratory syndrome ; Peripheral blood ; Phenotype ; Phenotypes ; Population genetics ; Populations ; Research and Analysis Methods ; SARS-CoV-2 - physiology ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Signatures ; Spleen ; T cells ; T-Lymphocytes - immunology ; Vaccines ; Ventilation ; Viral diseases ; Viral Load ; Viruses ; Weight loss ; West Nile virus</subject><ispartof>PLoS pathogens, 2021-01, Vol.17 (1), p.e1009287-e1009287</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Graham et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Graham et al 2021 Graham et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443</citedby><cites>FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443</cites><orcidid>0000-0001-8333-6607 ; 0000-0003-1374-8002 ; 0000-0001-5829-8477 ; 0000-0003-1372-8722 ; 0000-0002-4989-5381 ; 0000-0001-6579-0443 ; 0000-0003-3284-979X ; 0000-0001-6827-8701 ; 0000-0002-0781-7254 ; 0000-0003-1241-6268</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2490314839?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2490314839?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33513210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Subbarao, Kanta</contributor><creatorcontrib>Graham, Jessica B</creatorcontrib><creatorcontrib>Swarts, Jessica L</creatorcontrib><creatorcontrib>Leist, Sarah R</creatorcontrib><creatorcontrib>Schäfer, Alexandra</creatorcontrib><creatorcontrib>Menachery, Vineet D</creatorcontrib><creatorcontrib>Gralinski, Lisa E</creatorcontrib><creatorcontrib>Jeng, Sophia</creatorcontrib><creatorcontrib>Miller, Darla R</creatorcontrib><creatorcontrib>Mooney, Michael A</creatorcontrib><creatorcontrib>McWeeney, Shannon K</creatorcontrib><creatorcontrib>Ferris, Martin T</creatorcontrib><creatorcontrib>Pardo-Manuel de Villena, Fernando</creatorcontrib><creatorcontrib>Heise, Mark T</creatorcontrib><creatorcontrib>Baric, Ralph S</creatorcontrib><creatorcontrib>Lund, Jennifer M</creatorcontrib><title>Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>The COVID-19 pandemic has revealed that infection with SARS-CoV-2 can result in a wide range of clinical outcomes in humans. An incomplete understanding of immune correlates of protection represents a major barrier to the design of vaccines and therapeutic approaches to prevent infection or limit disease. This deficit is largely due to the lack of prospectively collected, pre-infection samples from individuals that go on to become infected with SARS-CoV-2. Here, we utilized data from genetically diverse Collaborative Cross (CC) mice infected with SARS-CoV to determine whether baseline T cell signatures are associated with a lack of viral control and severe disease upon infection. SARS-CoV infection of CC mice results in a variety of viral load trajectories and disease outcomes. Overall, a dysregulated, pro-inflammatory signature of circulating T cells at baseline was associated with severe disease upon infection. Our study serves as proof of concept that circulating T cell signatures at baseline can predict clinical and virologic outcomes upon SARS-CoV infection. Identification of basal immune predictors in humans could allow for identification of individuals at highest risk of severe clinical and virologic outcomes upon infection, who may thus most benefit from available clinical interventions to restrict infection and disease.</description><subject>Animal diseases</subject><subject>Animal models</subject><subject>Animals</subject><subject>Biology and Life Sciences</subject><subject>Body weight loss</subject><subject>Clinical outcomes</subject><subject>Collaboration</subject><subject>Coronaviruses</subject><subject>Correlation</subject><subject>COVID-19</subject><subject>COVID-19 - genetics</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - virology</subject><subject>Disease control</subject><subject>Female</subject><subject>Genetic aspects</subject><subject>Genetics</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Inbreeding</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Lungs</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Medicine and Health Sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Middle East respiratory syndrome</subject><subject>Peripheral blood</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Population genetics</subject><subject>Populations</subject><subject>Research and Analysis Methods</subject><subject>SARS-CoV-2 - physiology</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signatures</subject><subject>Spleen</subject><subject>T cells</subject><subject>T-Lymphocytes - immunology</subject><subject>Vaccines</subject><subject>Ventilation</subject><subject>Viral diseases</subject><subject>Viral Load</subject><subject>Viruses</subject><subject>Weight loss</subject><subject>West Nile virus</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqVUk1v1DAQjRCIlsI_QGCJCxx28cR27FyQlhUfK1UgdQtXy3EmW6-ycRonKyr-PA6bVl3UC_LB9vi9N56ZlyQvgc6BSXi_9UPXmHretqafA6V5quSj5BSEYDPJJH9873ySPAthSykHBtnT5IQxASwFepr8_mgC1q5Bckks1jVxu90Qb-0VNr6_aTGQtsPS2Z7sXedrv3GWmKYkpQsYqcT6po9xMrS-IevFxXq29D-Jayq0vYsh15Clr2tT-M70bo9k2fkQyM5ZfJ48qUwd8MW0nyU_Pn-6XH6dnX__slouzmc2y6CflZCBVFXGCmuR2soAFIxiYQTPhQJbyMIWAoGa-GRiWaAKEFKIjFvMOWdnyeuDblv7oKe-BZ3ynDLgiuURsTogSm-2uu3cznQ32hun_wZ8t9Gm652tURfIU24gFTaruCyESousxApUTqWJ6aLWhynbUOywtBj7Y-oj0eOXxl3pjd9rqaRguYoCbyeBzl8PGHq9c2GcjWnQD-O_FVMgZTbmevMP9OHqJtTGxALiaHzMa0dRvcgEVcAzmkbU_AFUXCXGYfkGKxfjR4R3R4TRCfir35ghBL1aX_wH9tsxlh-wdnRKh9Vd74Dq0fq3RerR-nqyfqS9ut_3O9Kt19kftEr_5g</recordid><startdate>20210129</startdate><enddate>20210129</enddate><creator>Graham, Jessica B</creator><creator>Swarts, Jessica L</creator><creator>Leist, Sarah R</creator><creator>Schäfer, Alexandra</creator><creator>Menachery, Vineet D</creator><creator>Gralinski, Lisa E</creator><creator>Jeng, Sophia</creator><creator>Miller, Darla R</creator><creator>Mooney, Michael A</creator><creator>McWeeney, Shannon K</creator><creator>Ferris, Martin T</creator><creator>Pardo-Manuel de Villena, Fernando</creator><creator>Heise, Mark T</creator><creator>Baric, Ralph S</creator><creator>Lund, Jennifer M</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8333-6607</orcidid><orcidid>https://orcid.org/0000-0003-1374-8002</orcidid><orcidid>https://orcid.org/0000-0001-5829-8477</orcidid><orcidid>https://orcid.org/0000-0003-1372-8722</orcidid><orcidid>https://orcid.org/0000-0002-4989-5381</orcidid><orcidid>https://orcid.org/0000-0001-6579-0443</orcidid><orcidid>https://orcid.org/0000-0003-3284-979X</orcidid><orcidid>https://orcid.org/0000-0001-6827-8701</orcidid><orcidid>https://orcid.org/0000-0002-0781-7254</orcidid><orcidid>https://orcid.org/0000-0003-1241-6268</orcidid></search><sort><creationdate>20210129</creationdate><title>Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice</title><author>Graham, Jessica B ; Swarts, Jessica L ; Leist, Sarah R ; Schäfer, Alexandra ; Menachery, Vineet D ; Gralinski, Lisa E ; Jeng, Sophia ; Miller, Darla R ; Mooney, Michael A ; McWeeney, Shannon K ; Ferris, Martin T ; Pardo-Manuel de Villena, Fernando ; Heise, Mark T ; Baric, Ralph S ; Lund, Jennifer M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animal diseases</topic><topic>Animal models</topic><topic>Animals</topic><topic>Biology and Life Sciences</topic><topic>Body weight loss</topic><topic>Clinical outcomes</topic><topic>Collaboration</topic><topic>Coronaviruses</topic><topic>Correlation</topic><topic>COVID-19</topic><topic>COVID-19 - genetics</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - virology</topic><topic>Disease control</topic><topic>Female</topic><topic>Genetic aspects</topic><topic>Genetics</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Inbreeding</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Lungs</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Medicine and Health Sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Middle East respiratory syndrome</topic><topic>Peripheral blood</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Population genetics</topic><topic>Populations</topic><topic>Research and Analysis Methods</topic><topic>SARS-CoV-2 - physiology</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signatures</topic><topic>Spleen</topic><topic>T cells</topic><topic>T-Lymphocytes - immunology</topic><topic>Vaccines</topic><topic>Ventilation</topic><topic>Viral diseases</topic><topic>Viral Load</topic><topic>Viruses</topic><topic>Weight loss</topic><topic>West Nile virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Graham, Jessica B</creatorcontrib><creatorcontrib>Swarts, Jessica L</creatorcontrib><creatorcontrib>Leist, Sarah R</creatorcontrib><creatorcontrib>Schäfer, Alexandra</creatorcontrib><creatorcontrib>Menachery, Vineet D</creatorcontrib><creatorcontrib>Gralinski, Lisa E</creatorcontrib><creatorcontrib>Jeng, Sophia</creatorcontrib><creatorcontrib>Miller, Darla R</creatorcontrib><creatorcontrib>Mooney, Michael A</creatorcontrib><creatorcontrib>McWeeney, Shannon K</creatorcontrib><creatorcontrib>Ferris, Martin T</creatorcontrib><creatorcontrib>Pardo-Manuel de Villena, Fernando</creatorcontrib><creatorcontrib>Heise, Mark T</creatorcontrib><creatorcontrib>Baric, Ralph S</creatorcontrib><creatorcontrib>Lund, Jennifer M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (ProQuest Medical &amp; Health Databases)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Graham, Jessica B</au><au>Swarts, Jessica L</au><au>Leist, Sarah R</au><au>Schäfer, Alexandra</au><au>Menachery, Vineet D</au><au>Gralinski, Lisa E</au><au>Jeng, Sophia</au><au>Miller, Darla R</au><au>Mooney, Michael A</au><au>McWeeney, Shannon K</au><au>Ferris, Martin T</au><au>Pardo-Manuel de Villena, Fernando</au><au>Heise, Mark T</au><au>Baric, Ralph S</au><au>Lund, Jennifer M</au><au>Subbarao, Kanta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2021-01-29</date><risdate>2021</risdate><volume>17</volume><issue>1</issue><spage>e1009287</spage><epage>e1009287</epage><pages>e1009287-e1009287</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>The COVID-19 pandemic has revealed that infection with SARS-CoV-2 can result in a wide range of clinical outcomes in humans. An incomplete understanding of immune correlates of protection represents a major barrier to the design of vaccines and therapeutic approaches to prevent infection or limit disease. This deficit is largely due to the lack of prospectively collected, pre-infection samples from individuals that go on to become infected with SARS-CoV-2. Here, we utilized data from genetically diverse Collaborative Cross (CC) mice infected with SARS-CoV to determine whether baseline T cell signatures are associated with a lack of viral control and severe disease upon infection. SARS-CoV infection of CC mice results in a variety of viral load trajectories and disease outcomes. Overall, a dysregulated, pro-inflammatory signature of circulating T cells at baseline was associated with severe disease upon infection. Our study serves as proof of concept that circulating T cell signatures at baseline can predict clinical and virologic outcomes upon SARS-CoV infection. Identification of basal immune predictors in humans could allow for identification of individuals at highest risk of severe clinical and virologic outcomes upon infection, who may thus most benefit from available clinical interventions to restrict infection and disease.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33513210</pmid><doi>10.1371/journal.ppat.1009287</doi><orcidid>https://orcid.org/0000-0001-8333-6607</orcidid><orcidid>https://orcid.org/0000-0003-1374-8002</orcidid><orcidid>https://orcid.org/0000-0001-5829-8477</orcidid><orcidid>https://orcid.org/0000-0003-1372-8722</orcidid><orcidid>https://orcid.org/0000-0002-4989-5381</orcidid><orcidid>https://orcid.org/0000-0001-6579-0443</orcidid><orcidid>https://orcid.org/0000-0003-3284-979X</orcidid><orcidid>https://orcid.org/0000-0001-6827-8701</orcidid><orcidid>https://orcid.org/0000-0002-0781-7254</orcidid><orcidid>https://orcid.org/0000-0003-1241-6268</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7374
ispartof PLoS pathogens, 2021-01, Vol.17 (1), p.e1009287-e1009287
issn 1553-7374
1553-7366
1553-7374
language eng
recordid cdi_plos_journals_2490314839
source Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database
subjects Animal diseases
Animal models
Animals
Biology and Life Sciences
Body weight loss
Clinical outcomes
Collaboration
Coronaviruses
Correlation
COVID-19
COVID-19 - genetics
COVID-19 - immunology
COVID-19 - virology
Disease control
Female
Genetic aspects
Genetics
Health aspects
Humans
Immune response
Immune system
Inbreeding
Infections
Inflammation
Lungs
Lymphocytes
Lymphocytes T
Male
Medicine and Health Sciences
Mice
Mice, Inbred C57BL
Middle East respiratory syndrome
Peripheral blood
Phenotype
Phenotypes
Population genetics
Populations
Research and Analysis Methods
SARS-CoV-2 - physiology
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Signatures
Spleen
T cells
T-Lymphocytes - immunology
Vaccines
Ventilation
Viral diseases
Viral Load
Viruses
Weight loss
West Nile virus
title Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T08%3A01%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Baseline%20T%20cell%20immune%20phenotypes%20predict%20virologic%20and%20disease%20control%20upon%20SARS-CoV%20infection%20in%20Collaborative%20Cross%20mice&rft.jtitle=PLoS%20pathogens&rft.au=Graham,%20Jessica%20B&rft.date=2021-01-29&rft.volume=17&rft.issue=1&rft.spage=e1009287&rft.epage=e1009287&rft.pages=e1009287-e1009287&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1009287&rft_dat=%3Cgale_plos_%3EA650814602%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c661t-d16178f63bcce0cfa11b30eba549581cb7bcb5e10afa1a32118b1575564ce9443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2490314839&rft_id=info:pmid/33513210&rft_galeid=A650814602&rfr_iscdi=true